parthenolide has been researched along with Cystic Fibrosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, M; DiDonato, J; Li, J; Masters, S; Saadane, A | 1 |
Cabrini, G; Melotti, P; Nicolis, E; Pavirani, A; Rolfini, R; Tamanini, A | 1 |
2 other study(ies) available for parthenolide and Cystic Fibrosis
Article | Year |
---|---|
Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.
Topics: Active Transport, Cell Nucleus; Animals; Bronchoalveolar Lavage Fluid; Cell Line; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; I-kappa B Kinase; Inflammation; Interleukin-1beta; Interleukin-8; Lipopolysaccharides; Lung; Male; Mice; Mice, Knockout; NF-kappa B; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2007 |
Activation of NF-kB mediates ICAM-1 induction in respiratory cells exposed to an adenovirus-derived vector.
Topics: Acetylcysteine; Adenoviridae; Antioxidants; Cell Line; Chloramphenicol O-Acetyltransferase; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Intercellular Adhesion Molecule-1; Lung; NF-kappa B; Peptides; Pyrrolidines; RNA, Messenger; Sesquiterpenes; Thiocarbamates; Translocation, Genetic | 2001 |